Helen McIlleron

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

Jotam G. Pasipanodya, Helen McIlleron, A. Burger et al. · The Journal of Infectious Diseases · 2013 · 456 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 444 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients

Helen McIlleron, Peter Wash, André Burger et al. · Antimicrobial Agents and Chemotherapy · 2006 · 247 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears

Andreas H. Diacon, R. F. Patientia, Amour Venter et al. · Antimicrobial Agents and Chemotherapy · 2007 · 199 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children

Anna Turkova, Genevieve H. Wills, Eric Wobudeya et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2022 · 173 citations

Medicine, Infectious Diseases, Pediatrics +17